
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 1051 | 1146 | 1068 | 1320 | 1820 |
Fund Return | 4.33% | 5.14% | 14.63% | 2.22% | 5.71% | 6.17% |
Place in category | 194 | 409 | 470 | 395 | 464 | 388 |
% in Category | 32 | 76 | 85 | 77 | 90 | 98 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Rydex NASDAQ-100 Inv | 1.53B | -0.70 | 13.15 | 16.37 | ||
Rydex S&P 500 H | 131.03M | 26.17 | 9.59 | 11.44 | ||
Rydex Variable NASDAQ 100 | 109.75M | 2.10 | 11.82 | 16.98 | ||
Rydex Variable NASDAQ 100 2x Strate | 99.68M | 3.53 | 14.27 | 29.18 | ||
Rydex NASDAQ 100 Fund Class A | 105.33M | 23.67 | 8.32 | 16.38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Explorer Adm | 18.36B | -2.10 | 3.52 | 9.47 | ||
Vanguard Small Cap Growth Index Adm | 14.11B | -2.32 | 4.38 | 8.29 | ||
Neuberger Berman Genesis R6 | 4.33B | -2.79 | 3.60 | 9.16 | ||
T. Rowe Price Instl Small-Cap Stock | 4.25B | -0.08 | 3.93 | 9.50 | ||
T. Rowe Price QM US Small-Cap Gr Eq | 4.18B | -1.75 | 5.76 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Cinemark | US17243V1026 | 1.57 | 26.10 | +4.36% | |
InterDigital | US45867G1013 | 1.48 | 221.00 | +0.89% | |
DXP Enterprises | US2333774071 | 1.47 | 88.86 | +4.37% | |
Protagonist Therapeutics | US74366E1029 | 1.47 | 54.35 | -0.31% | |
TG | US88322Q1085 | 1.44 | 42.49 | +6.54% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review